caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1417275652

John AllenM.D.

Hematology-OncologyOxford, MSI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
1,742
Beneficiaries
—
Total drug cost
$3.4M
Distinct drugs
42
Brand share
32.4%
Top prescribed drugs
Letrozole142 claims
Potassium Chloride136 claims
Tamoxifen Citrate116 claims
Ondansetron112 claims
Hydrocodone/Acetaminophen83 claims
QUALITY · MIPS · 2024
Final MIPS score
81.9
Quality
64.8
Cost
74.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.29%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,238
Unique beneficiaries
—
Total services
2,551
Distinct HCPCS
11
Medicare payment
$119K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 52 Hematology-Oncology providers in MS — above median (cohort median 1,630).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
190
By payment type
Food and Beverage$3K
Education$142